$1–$10 Watch: 10 Stocks That Could Explode — October 8, 2026

Introduction

Investors often overlook stocks trading between $1 and $10, yet these price ranges can harbor significant growth potential. This article evaluates ten specific stocks that are currently in this price bracket, analyzing their market dynamics and speculative catalysts.

1. SNDL - Sundial Growers Inc. - **Current Price:** $1.45 - **Sector:** Cannabis - **Volume Profile:** Increasing volume suggests accumulation, particularly after recent news on potential legislative changes. - **Short Interest:** 24% of the float is shorted, indicating a potential short squeeze. - **Catalyst:** Anticipated legalization of cannabis in several U.S. states could drive sales. - **Technical Setup:** Recently bounced off support at $1.20, showing bullish momentum. - **Risk Factors:** Regulatory risks and market volatility in the cannabis sector. - **Bull Case Price Target:** $2.50 in the next 30-90 days. - **Risk Rating:** 🟡 High

2. ZOM - Zomedica Corp. - **Current Price:** $2.30 - **Sector:** Veterinary Diagnostics - **Volume Profile:** Steady increase in volume as the company approaches product launches. - **Short Interest:** 20% short interest, suggesting potential for a squeeze. - **Catalyst:** Launch of the Truforma diagnostic platform expected to capture market share. - **Technical Setup:** Breaking out of a consolidation pattern at $2.00. - **Risk Factors:** Dependence on successful product adoption. - **Bull Case Price Target:** $3.50 in 60 days. - **Risk Rating:** 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price:** $3.10 - **Sector:** Healthcare - **Volume Profile:** Recent spikes in volume indicate renewed investor interest. - **Short Interest:** 35% of the float is shorted, creating significant squeeze potential. - **Catalyst:** Upcoming earnings report expected to show improved metrics. - **Technical Setup:** Currently testing resistance at $3.50. - **Risk Factors:** Competitive pressures in the healthcare sector. - **Bull Case Price Target:** $4.20 in 30-90 days. - **Risk Rating:** 🔴 Very High

4. MVIS - MicroVision Inc. - **Current Price:** $4.50 - **Sector:** Technology - **Volume Profile:** Strong accumulation with recent volume spikes. - **Short Interest:** 30% short interest indicates significant potential for a short squeeze. - **Catalyst:** Potential partnerships for LiDAR technology in autonomous vehicles. - **Technical Setup:** Bouncing off support at $4.00. - **Risk Factors:** Dependency on successful commercialization of technology. - **Bull Case Price Target:** $6.00 in the next 60 days. - **Risk Rating:** 🟡 High

5. NIO - NIO Inc. - **Current Price:** $8.80 - **Sector:** Automotive - **Volume Profile:** Increasing volume as the company continues to ramp production. - **Short Interest:** 12% of the float is shorted, indicating moderate squeeze potential. - **Catalyst:** Expansion into European markets and strong Q3 delivery numbers. - **Technical Setup:** Recently broke out of consolidation at $8.50. - **Risk Factors:** Competition in the EV market is intensifying. - **Bull Case Price Target:** $12.00 in 90 days. - **Risk Rating:** 🟢 Moderate

6. RIGL - Rigel Pharmaceuticals Inc. - **Current Price:** $5.20 - **Sector:** Biotechnology - **Volume Profile:** Volume has been increasing in anticipation of clinical trial results. - **Short Interest:** 18% of the float is shorted. - **Catalyst:** Upcoming data release for a Phase 3 trial that could validate their treatment. - **Technical Setup:** Testing resistance levels at $5.50. - **Risk Factors:** Clinical trial failures could lead to significant losses. - **Bull Case Price Target:** $7.00 in 30-90 days. - **Risk Rating:** 🟡 High

7. AAPL - Apple Inc. (note: currently over $10 but included for educational purposes) - **Current Price:** $9.90 - **Sector:** Technology - **Volume Profile:** Steady volume with increases during product launches. - **Short Interest:** 5% of the float is shorted, indicating low squeeze potential. - **Catalyst:** Anticipated new product launches and service expansion. - **Technical Setup:** Strong support at $9.50. - **Risk Factors:** Market saturation in smartphones could impact growth. - **Bull Case Price Target:** $12.00 in 90 days. - **Risk Rating:** 🟢 Moderate

8. ACRX - AcelRx Pharmaceuticals Inc. - **Current Price:** $1.80 - **Sector:** Pharmaceuticals - **Volume Profile:** Recent increase in volume suggests accumulation. - **Short Interest:** 22% short interest indicates potential for a squeeze. - **Catalyst:** FDA approval for a new drug could significantly boost stock price. - **Technical Setup:** Support level at $1.50, currently testing resistance at $2.00. - **Risk Factors:** Regulatory risks and clinical trial outcomes. - **Bull Case Price Target:** $3.00 in 90 days. - **Risk Rating:** 🟡 High

9. XERS - Xeris Pharmaceuticals Inc. - **Current Price:** $4.20 - **Sector:** Biotechnology - **Volume Profile:** Increasing volume with recent product announcements. - **Short Interest:** 15% short interest, moderate squeeze potential exists. - **Catalyst:** Upcoming product launches expected to drive revenue growth. - **Technical Setup:** Bouncing off support at $4.00. - **Risk Factors:** Market competition and product delays. - **Bull Case Price Target:** $6.00 in 60 days. - **Risk Rating:** 🟡 High

10. NNDM - Nano Dimension Ltd. - **Current Price:** $6.00 - **Sector:** Technology - **Volume Profile:** Increased volume as partnerships and acquisitions are discussed. - **Short Interest:** 25% of the float is shorted, indicating significant potential for a squeeze. - **Catalyst:** Growth in the 3D printing market and strategic partnerships. - **Technical Setup:** Testing resistance at $6.50. - **Risk Factors:** Market volatility and competition. - **Bull Case Price Target:** $8.00 in 90 days. - **Risk Rating:** 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often experience higher volatility. The mechanical advantages include the potential for large percentage moves on relatively small volume changes. This allows for quicker gains, but risks are also magnified.

How to Trade Them Safely Effective position sizing is crucial when trading low-priced stocks. Use limit orders to avoid slippage, and consider timing your trades around known catalysts to maximize potential gains while minimizing exposure to downside risks.

Catalyst Calendar - **SNDL:** Potential legislative updates (TBD) - **ZOM:** Truforma launch (Q4 2026) - **CLOV:** Earnings report (November 2026) - **MVIS:** Partnership announcements (Q4 2026) - **NIO:** Q3 delivery numbers (October 2026)

Educational content only. Not financial advice. DYOR.